FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/094706 [Registered on: 12/09/2025] Trial Registered Prospectively
Last Modified On: 11/09/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Self Warming Blanket for Newborns]  
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Helping Newborn Babies Stay Warm: A Study of a Novel Self Warming Blanket 
Scientific Title of Study   Efficacy of a Novel Self-Warming blanket for thermoregulation in Neonates - An Open labelled , parallel arm, Randomized Controlled Trial 
Trial Acronym  NeoSWaT 
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrPallavi Samariya 
Designation  Assistant Professor 
Affiliation  All India Institute of Medical Sciences, Mangalagiri 
Address  Department of Pediatrics All India Institute of Medical Sciences, Mangalagiri, Guntur- AP

Guntur
ANDHRA PRADESH
522503
India 
Phone  8424064142  
Fax    
Email  pallavisamariya04@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrPallavi Samariya 
Designation  Assistant Professor 
Affiliation  All India Institute of Medical Sciences, Mangalagiri 
Address  Department of Pediatrics All India Institute of Medical Sciences, Mangalagiri, Guntur- AP


ANDHRA PRADESH
522503
India 
Phone  8424064142  
Fax    
Email  pallavisamariya04@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Arun Babu T 
Designation  Professor and Head 
Affiliation  All India Institute of Medical Sciences, Mangalagiri 
Address  Department of Pediatrics All India Institute of Medical Sciences, Mangalagiri, Guntur- AP

Guntur
ANDHRA PRADESH
522503
India 
Phone  9944701700  
Fax    
Email  babuarun@yahoo.com  
 
Source of Monetary or Material Support  
All India Institute of Medical Sciences, Mangalagiri, Guntur, AP, India- 522503 
 
Primary Sponsor  
Name  Dr Pallavi Samariya 
Address  All India Institute of Medical Sciences, Mangalagiri, Guntur, Andhra Pradesh, India- 522503 
Type of Sponsor  Other [Self funded] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pallavi Samariya  All India Institute of Medical Sciences, Mangalagiri, Guntur, AP, India-522503  Room No-321,OPD Block, Department of Pediatrics
Guntur
ANDHRA PRADESH 
8424064142

pallavisamariya04@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC AIIMS Mangalagiri   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Stable newborn delivered between 30 and 40 weeks of gestation within first 28 days of life  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Conventional Blanket for Newborns  Conventional Blanket for Newborns will be assigned for 8 hours to the selected participants based on randomisation to check for temerparature stability 
Intervention  Novel Self Warming Blanket   Novel Self Warming Blanket will be assigned for 8 hours to the selected participants based on randomisation to check for temerparature stability  
 
Inclusion Criteria  
Age From  0.00 Day(s)
Age To  28.00 Day(s)
Gender  Both 
Details  Stable newborn delivered between 30 and 40 weeks of gestation within first 28 days of life
 
 
ExclusionCriteria 
Details  Newborns born before 30 weeks of gestation
Critically ill newborn requiring NICU admission
Newborn with major congenital malformations
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Proportion of newborns maintaining normal body temperature (36.5°C to 37.5°C) upon usage of novel self warming blanket vs conventional blanket   Proportion of newborns maintaining normal body temperature (36.5°C to 37.5°C) during 8 hours of usage of novel self warming blanket vs conventional blanket  
 
Secondary Outcome  
Outcome  TimePoints 
The trial also aims at evaluating any adverse events reported with usage of these blankets in newborn  The newborns will be monitored for any side effects at baseline, as well continuous hourly monitoring will be done till 8 hours of usage of novel self warming blanket vs conventional blanket. 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   01/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="9"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Neonates satisfying the eligibility criteria will be enrolled in the study after obtaining written informed consent from the parents/legal guardian/caretaker

Eligible newborns will then be randomized using a digitally generated sequence into two groups

Group A will receive a Novel Self Warming Blanket and group B will receive the normal blanketThe procedure of randomization will be conducted by a person who has no role in the collection of data randomization analysis of data or allocation of the intervention A sequence with a random order will be derived using a software application. Randomization of the sequence will be further enhanced by generating tables of variable block sizes using computer software Concealment of the allocation of the intervention will be implemented by the usage of opaque chronologically numbered sealed envelopes each corresponding to the assigned sequence An open-label study design has been adopted due to the operational requirement for air activation of the heating element integrated within the self warming blanket A structured questionnaire will be used to gather demographic information and a comprehensive history regarding antenatal details maternal medication use etc will also be recorded Additionally a thorough physical examination will be conducted to assess for any systemic involvement.

This Self-Warming blanket is specifically engineered to integrate two essential components a thermal blanket and a heating element The blanket is constructed from hypoallergenic fabric combined with hospital-grade polypropylene material and polyurethane foam, providing insulation to minimize heat loss in  infants. While the insulating layer helps to slow down the loss of body heat, it alone is insufficient to maintain a thermoneutral temperature, as preterm infants lack the ability to generate adequate heat on their own To address this, the design includes a dedicated compartment for a heating element, which serves as a controlled and consistent external heat source This heating component is designed to maintain a stable thermoneutral temperature for up to 8 hours, ensuring the infant remains warm during critical periods such as transport or postnatal stabilizationThe heating element is strategically positioned on the back side of the blanket and is separated from the infant’s contact surface by four protective layers comprising fabric and foam. This multilayered barrier ensures that the heating element remains completely isolated thereby eliminating any risk of direct contact with the newborn

The heating component utilizes ready-to-use air-activated heat packs which are widely employed globally for thermal insulation in cold environments These heat packs contain only non-toxic substances including iron salt water and insulating material such as vermiculite and activated carbon These materials are securely enclosed within multiple protective layers to prevent any leakage of the active ingredients

Upon exposure to air, the iron within the mixture undergoes a controlled oxidation process converting to iron oxide (rust) which generates heat Owing to the gradual nature of this chemical reaction the heating pack is engineered to deliver warmth in a slow sustained manner maintaining a consistent temperature over an extended duration.

Utilizing air activated heating technology, the Self Warming blanket  becomes ready for use within 15 minutes of exposure to air and provides consistent warmth for up to 8 hoursAfter use, a heating element made with all non-toxic, eco-friendly ingredients can be safely disposed of with solid wasteThe product is tested within the laboratory for obtaining the temperature profile of the surface in contact with the babyThe temperature remains between 36.5 – 38.0 °C and slowly decreases over a period of time. There is no variation in Warm and Cold temperature while using the blanket


Following the initiation of the intervention, all newborns will be monitored continuously using a temperature probe with set limits with an alarm Assessment of the Prechtl score will also be done hourly over the next 8 hours to assess their condition After  8 hours of blanket usage, newborns will undergo a re-evaluation of the same parameters at 0 5 and 30-minute intervals This approach will facilitate a more detailed assessment of their temperature stability and ensure continuous and appropriate monitoring of their overall condition Any adverse effect noted during the usage of blanket will be documented


 
Close